Zepbound and Foundayo on Hims & Hers: What the Lilly Deal Means
Short answer: as of Nov 6, 2026, you can get Lilly’s Zepbound shot and Foundayo pill through Hims & Hers without being bounced to another site. Self-pay prices start at $149 a month for Foundayo and $299 a month for Zepbound, the same prices Lilly charges on its own LillyDirect platform. It is not a discount, it is a shorter path to an FDA-approved drug, and it still requires a prescription from a licensed provider.
Key facts
- Announced Nov 6, 2026: Eli Lilly and Hims & Hers agreed that Zepbound (tirzepatide) and Foundayo (orforglipron) can be bought directly on the Hims & Hers platform, per Reuters and PharmExec.
- Same prices as LillyDirect: self-pay starts at $149/month for Foundayo and $299/month for Zepbound. The prices are not exclusive to Hims & Hers.
- Zepbound tiers (Lilly, as of Nov 2026): $299 (2.5 mg), $399 (5 mg), and $449 for 7.5 to 15 mg KwikPen if each refill lands within 45 days; otherwise $499 to $699.
- No Lilly knockoffs: Hims & Hers committed not to sell compounded copies of Lilly’s obesity drugs.
- Prescription still required: a licensed provider on the platform decides whether either drug fits you.
What actually changed?
Before this deal, a Hims & Hers patient who wanted a Lilly drug had to leave the site and finish the order on LillyDirect, Lilly’s cash-pay pharmacy. Now the whole thing happens in one place: a consultation, a prescription if the provider thinks it is appropriate, and the FDA-approved drug shipped home, per PharmExec.
Lilly USA president Ilya Yuffa told Reuters the old route was “not fully straightforward.” The deal also matters because Lilly says 40% to 45% of Zepbound sales already go through self-pay channels, per Reuters. That is a lot of people paying cash who now get a simpler checkout.
Novo Nordisk got there first. It has sold Wegovy and Ozempic through Hims & Hers since March 2026, with the Wegovy pill from $149/month and the Wegovy pen from $199/month, per Reuters. So the platform now carries brand-name drugs from both of the big GLP-1 makers.
How much does Zepbound cost through Hims & Hers?
Hims & Hers matches LillyDirect, so Lilly’s own price page is the reference. As of Nov 2026, for a one-month KwikPen or vial supply:
| Zepbound dose | Self-pay price | Regular price |
|---|---|---|
| 2.5 mg (starting dose) | $299 | $299 |
| 5 mg | $399 | $399 |
| 7.5 mg | $449 (offer) | $499 |
| 10, 12.5 or 15 mg | $449 (offer) | $699 |
The $449 offer applies to the first fill and to refills completed within 45 days of the previous delivery. Miss that window and you pay the regular price. Lilly says the $299 price is for the KwikPen or vials, not the single-dose pen, and that its savings cards end Dec 31, 2026 and can change without notice.
Foundayo starts at $149/month, per Reuters and PharmExec. Higher doses cost more; confirm the tier at checkout. Telehealth platforms usually bill a membership or visit fee on top of the drug, so add that to the monthly total. Our GLP-1 price comparison lays the numbers side by side.
Why this is good news
Three reasons:
- Fewer steps to the real thing. Brand-name, FDA-approved tirzepatide and orforglipron, with a known manufacturer and a full label, now sit one click from a telehealth consult.
- Price transparency. The price is the same as Lilly’s public price. No platform markup on the drug itself.
- Less pull toward copies. Hims & Hers committed not to sell compounded versions or knockoffs of Lilly’s obesity drugs. For why sourcing matters, see compounded vs brand-name semaglutide.
The fine print
Good deal, real limits:
- It is still cash pay for most people. $299 to $699 a month for Zepbound adds up fast. If you have insurance, check coverage first: Lilly’s insured savings card can bring a covered single-dose pen to as little as $25 a month, with annual limits.
- The 45-day rule matters. Late refills on higher Zepbound doses jump from $449 to $499 or $699.
- Side effects are the same wherever you buy. The Zepbound label lists nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion among the most common side effects (5% or more of patients). Foundayo’s label lists a similar set, plus headache and bloating.
- Both carry a boxed warning about thyroid C-cell tumors seen in rodents. Neither is for people with a personal or family history of medullary thyroid carcinoma or MEN 2, per the FDA labels.
- Not for everyone. Both are approved for adults with obesity, or overweight plus a weight-related health problem. Zepbound is also approved for moderate to severe sleep apnea in adults with obesity.
What it means for you
If you were already looking at Zepbound or Foundayo and paying cash, this is one more legit route with no price penalty. It is not the only one: LillyDirect, other telehealth services and your own doctor can prescribe the same drugs at the same Lilly prices. Whatever route you pick, the next step is a licensed provider who can check whether you qualify, talk through side effects and decide on a dose. Our GLP-1 telehealth guide explains how online prescribing works, Oral Wegovy vs Foundayo compares the two pills, and our legal status tracker covers where unapproved peptides stand.
Sources
- Reuters via Yahoo Finance: Lilly to sell obesity drugs directly on Hims & Hers site (Nov 6, 2026)
- PharmExec: Hims & Hers partners with Eli Lilly to sell obesity medicines (Nov 6, 2026)
- Lilly: Zepbound coverage and savings, self-pay prices
- Lilly: Zepbound prescribing information (revised Aug 2026)
- Lilly: Foundayo prescribing information (revised July 2026)
Educational content only, not medical advice. Prices and offers can change; confirm current pricing and eligibility with a licensed provider or the manufacturer.